These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5650691)

  • 1. The identification of some human metabolites of norgestrel, a new progestational agent.
    DeJongh DC; Hribar JD; Littleton P; Fotherby K; Rees RW; Shrader S; Foell TJ; Smith H
    Steroids; 1968 May; 11(5):649-66. PubMed ID: 5650691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of norgestimate in women.
    Alton KB; Hetyei NS; Shaw C; Patrick JE
    Contraception; 1984 Jan; 29(1):19-29. PubMed ID: 6734203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of norgestrel by the human endometrium and myometrium in vitro.
    Uniyal JP; Buckshee K; Hingorani V; Laumas KR
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):155-66. PubMed ID: 576181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ( )-6,6-Difluoronorgestrel, a new synthetic hormonal steroid.
    Johnson AL
    J Med Chem; 1972 Apr; 15(4):360-3. PubMed ID: 5019549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
    Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of contraceptive steroid hormones by human intestinal clostridia.
    Bokkenheuser VD; Winter J; Cohen BI; O'Rourke S; Mosbach EH
    J Clin Microbiol; 1983 Sep; 18(3):500-4. PubMed ID: 6630441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting contraceptive agents: analysis and purification of steroid esters.
    Matlin SA; Chan L; Hadjigeogiou P; Prazeres MA; Mehani S; Roshdi S
    Steroids; 1983 Mar; 41(3):361-7. PubMed ID: 6419409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
    Ling WY; Wrixon W; Acorn T; Wilson E; Collins J
    Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
    El Hakim SM; Abdin FH; Kandil O
    Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.